Regentis Biomaterials Plans European Surgeon Training for GelrinC Rollout
June 8, 2026 — Regentis Biomaterials announces European surgeon training for GelrinC, a CE Mark-approved cell-free knee cartilage implant, starting Q3 2026 at Humanitas Research Hospital in Milan.